4431
敏成健康
0.00%
(0.00)
敏成健康 (4431.TW) 2025Q4 financial report shows revenue of 995.04M TWD, with a YoY growth rate of 3.54%. This figure indicates that 敏成健康 (4431.TW)’s operational performance has remained fundamentally stable. The moderate growth rate reflects a relatively steady market environment. Investors are advised to continuously and closely monitor the company’s future quarterly financial performance and key strategic adjustments. For a more comprehensive and objective assessment of 敏成健康 (4431.TW)’s future growth potential and investment opportunities, it is recommended to incorporate Growin AI Value Analysis for a thorough and prudent evaluation.